Date Announcement
30/08/2023 Appendix 4E and Preliminary Final Report
22/08/2023 Acquisition of Face MediGroup Presentation
22/08/2023 Anagenics to Acquire Face MediGroup
22/08/2023 Proposed issue of securities – AN1
27/06/2023 FY23 Financial Performance and Business Update
28/04/2023 Appendix 4C and Quarterly Activity Report
18/04/2023 Notification of cessation of securities – AN1
05/04/2023 Application for quotation of securities – AN1
29/03/2023 CEO Appointment
14/03/2023 Change in substantial holding
14/03/2023 Change of Director’s Interest Notice x2
13/03/2023 Application for quotation of securities – AN1
10/03/2023 Results of Retail Entitlement Offer
28/02/2023 Change in substantial holding
28/02/2023 Change in substantial holding from HNG
24/02/2023 Application for quotation of securities – AN1
21/02/2023 Despatch of Retail Offer Booklet
21/02/2023 Entitlement Offer – Letter to Ineligible Shareholders
17/02/2023 Application for quotation of securities – AN1
16/02/2023 Initial Director’s Interest Notice – Matthews
16/02/2023 Results of Institutional Entitlement Offer
14/02/2023 Cleansing Notice
14/02/2023 Entitlement Offer – Letter to Option Holders
14/02/2023 Entitlement Offer and Company Update
14/02/2023 Investor Presentation
14/02/2023 Proposed issue of securities – AN1
14/02/2023 Trading Halt
13/02/2023 Appendix 4D and Half Year Report
25/01/2023 Appendix 4C and Quarterly Activity Report
13/01/2023 Corporate update
13/01/2023 Proposed issue of securities
03/01/2023 Notification regarding unquoted securities

Let’s get in touch

Got a question? Email us

    Register for Investor Alerts